These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37794793)
1. Efficacy of darinaparsin for EBV-associated B-cell lymphoma in a heavily treated elderly patient with angioimmunoblastic T-cell lymphoma: a case report. Ikeda D; Oura M; Uehara A; Tabata R; Narita K; Takeuchi M; Matsue K Leuk Lymphoma; 2024 Jan; 65(1):132-135. PubMed ID: 37794793 [No Abstract] [Full Text] [Related]
2. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat. Smeltzer JP; Viswanatha DS; Habermann TM; Patnaik MM Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus present in T cells or B cells shows differential effects on hemophagocytic symptoms associated with outcome in T-cell lymphomas. Chen YP; Jones D; Chen TY; Chang KC Leuk Lymphoma; 2014 Sep; 55(9):2038-47. PubMed ID: 24180328 [TBL] [Abstract][Full Text] [Related]
4. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. Yang QX; Pei XJ; Tian XY; Li Y; Li Z Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma. Poon F; Ieremia E; Collins G; Matin RN Am J Dermatopathol; 2019 Dec; 41(12):927-930. PubMed ID: 31599749 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma. Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340 [TBL] [Abstract][Full Text] [Related]
7. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma. Eladl AE; Shimada K; Suzuki Y; Takahara T; Kato S; Kohno K; Elsayed AA; Wu CC; Tokunaga T; Kinoshita T; Sakata-Yanagimoto M; Nakamura S; Satou A Cancer Med; 2020 Jan; 9(2):678-688. PubMed ID: 31793218 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression. Brown HA; Macon WR; Kurtin PJ; Gibson LE J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382 [TBL] [Abstract][Full Text] [Related]
17. The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH. Liang JH; Lu L; Zhu HY; Li W; Fan L; Li JY; Xu W Cancer Res Treat; 2019 Jan; 51(1):150-157. PubMed ID: 29621877 [TBL] [Abstract][Full Text] [Related]
18. Leukocytoclastic vasculitis with IgA deposits in angioimmunoblastic T cell lymphoma. Sugaya M; Nakamura K; Asahina A; Tamaki K J Dermatol; 2001 Jan; 28(1):32-7. PubMed ID: 11280462 [TBL] [Abstract][Full Text] [Related]